Literature DB >> 3398064

Accrual to clinical trials.

R E Wittes, M A Friedman.   

Abstract

Mesh：

Year:  1988        PMID： 3398064     DOI： 10.1093/jnci/80.12.884

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  11 in total

1.  A web-based screening and accrual strategy for a cancer prevention clinical trial in healthy smokers.

Authors:  Arash Mohebati; Allison Knutson; Xi Kathy Zhou; Judith J Smith; Powel H Brown; Andrew J Dannenberg; Eva Szabo
Journal:  Contemp Clin Trials       Date:  2012-07-05       Impact factor: 2.226

2.  Designing clinical protocols for optimal use: measuring attributes of treatment and cancer control trials.

Authors:  J E Veney; W P Kory; J M Barnsley; A D Kaluzny
Journal:  J Med Syst       Date:  1991-12       Impact factor: 4.460

3.  Predicting accrual achievement: monitoring accrual milestones of NCI-CTEP-sponsored clinical trials.

Authors:  Steven K Cheng; Mary S Dietrich; David M Dilts
Journal:  Clin Cancer Res       Date:  2011-03-29       Impact factor: 12.531

4.  Randomized controlled trial comparing gastric cancer screening by gastrointestinal X-ray with serology for Helicobacter pylori and pepsinogens followed by gastrointestinal endoscopy.

Authors:  Takuji Gotoda; Hideki Ishikawa; Hirohide Ohnishi; Kentaro Sugano; Chika Kusano; Chizu Yokoi; Yutaka Matsuyama; Fuminori Moriyasu
Journal:  Gastric Cancer       Date:  2014-08-13       Impact factor: 7.370

5.  Effective Strategies for Maintaining Research Participation in Clinical Trials.

Authors:  Allen Zweben; Lisa M Fucito; Stephanie S O'Malley
Journal:  Drug Inf J       Date:  2009-07

Review 6.  Experimental and clinical studies alternating chemotherapy and radiotherapy.

Authors:  W B Looney; H A Hopkins; M Tubiana
Journal:  Cancer Metastasis Rev       Date:  1989-06       Impact factor: 9.264

7.  Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG)).

Authors:  S Marsoni; V Torri; M G Valsecchi; C Belloni; U Bianchi; G Bolis; C Bonazzi; N Colombo; A Epis; G Favalli
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

8.  Quality evaluation of investigator-initiated trials using post-approval cancer drugs in Japan.

Authors:  Shunsuke Kondo; Hiroko Hosoi; Kota Itahashi; Jun Hashimoto
Journal:  Cancer Sci       Date:  2017-05-16       Impact factor: 6.716

9.  Patients' perspectives and motivators to participate in clinical trials with novel therapies for rheumatoid arthritis.

Authors:  G Udrea; B Dumitrescu; M Purcarea; I Balan; E Rezus; D Deculescu
Journal:  J Med Life       Date:  2009 Apr-Jun

10.  What constitutes a "clinical trial"?: a survey of oncology professionals.

Authors:  James R Wright; Brenda Kowaleski; Jonathan Sussman
Journal:  Trials       Date:  2008-03-03       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.